The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C

Abstract

assessment of hepatitis C and genotype, as well as the degree of hepatic fibrosis by Fibroscan, biochemical and complete blood count indices carried out. Results. The study results showed high efficacy of the generic DAAs treatment in patients with chronic HCV over 12 weeks. The SVR rate made up 90.3% in Sofosbuvir + Ledipasvir therapy and